Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
05 September 2026
| Name: | UNIVERSAL BIOSENSORS INC. (UBI) |
| ISIN: | AU000000UBI2 |
| Date of Listing: | 13 December 2006 |
| Date of Delisting: | 28 August 2026 |
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 28 August 2026.Legal Status:
ACN*: 121 559 993ABN: 51 121 559 993
Registration Date: 04 September 2006
Capital Gains Tax (CGT) Status:
The securities in this entity, in our opinion, are of little or no value. We have made that assessment by reference to the circumstances leading to a suspension and/or delisting, the length of a suspension, share trading history and last on-market share price, most recent financial and cash flow statements, prospects (including likelihood of re-financing), and other factors including in particular whether the entity is in external administration. If you are seeking to crystallise a capital loss on your securities, that process can be easily and quickly initiated at our online Worthless Shares facility here: https://www.delisted.com.au/sell-worthless-and-other-securities/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
* ARBN if foreign entity
REGISTRY:
BoardRoom Australia
Level 8, 210 George Street, Sydney NSW 2000
GPO Box 3993 Sydney NSW 2001
Tel : 1300 737 760 (in Australia) +61 2 9290 9600 (International)
Fax : Within Australia: 1300 653 459 Outside Australia: +61 2 9279 0664
RegistryWebsite RegistryEmail
As from the close of trading on Friday, 28 August 2026 the abovementioned company was removed from ASX | 28/08/2026 |
we understand the company failed to pay its annual listing fees in respect of the year ending 30 June 2027 | 28/08/2026 |
The company is currently facing the suspension of its securities from the ASX Official Quotation due to an unpaid annual listing fee for the year ending 30 June 2027. Under Listing Rule 17.15, we are required to settle this outstanding amount by 5:00 PM AEST on Friday, 28 August 2026. Immediate action is essential, as failure to complete this payment before the deadline will result in the company being permanently removed from the Official List at the close of trading on that same day. | 24/08/2026 |
Securities of the company have been suspended for over three months. Each long-term suspended entity requires its name and ASX code, details of unlodged periodic reports under Listing Rule 17.5, the one-year deadline for the oldest outstanding report, and the two-year deadline to resume trading to ASX's satisfaction. Failure to meet these deadlines results in removal from the official list, typically effective from the first trading day after the deadline. | 10/07/2026 |
Securities of companies suspended over three months will be removed from the official list if they fail to meet 1 or 2 year deadlines, effective from the next trading day after deadlines. | 17/04/2026 |
Entities suspended for over three months face deadlines for lodging outstanding reports and resuming trading. Failure to meet one or two-year deadlines results in removal from the official list, effective the next trading day. | 22/01/2026 |
Creditors resolve to place the Company Universal Biosensors Pty Limited into liquidation and the Administrators (David Hardy, James Dampney and Emily Seeckts of KPMG) are appointed Liquidators of the Company | 24/09/2025 |
The company's securities will be suspended from quotation effective immediately due to a breach of Listing Rule 12.2. This action follows the announcement of voluntary administrators being appointed to Universal Biosensors Pty Limited on August 20, 2025. ASX determined that UBI's financial condition is inadequate for continued quotation. Suspension will remain in place until UBI demonstrates compliance with Listing Rules and it is deemed appropriate for reinstatement. | 22/08/2025 |
David Hardy, James Dampney and Emily Seeckts of KPMG were appointed as joint and several voluntary administrators of Universal Biosensors Pty Limited. | 20/08/2025 |
The suspension of trading in the securities of Universal Biosensors Inc. will be lifted immediately following the release by UBI of an announcement regarding UBI signing a non-binding term sheet for a senior secured loan facility. | 02/07/2025 |
The company has signed a non-binding term sheet for a senior secured loan facility of up to A$8.5 million with Viburnum Funds Pty Ltd. The transaction is subject to securityholder approval and formal documentation negotiation. The company plans to undertake an equity raising for existing securityholders. | 02/07/2025 |
The company's securities will be suspended from quotation under Listing Rule 17.2 pending an announcement. The suspension will continue until the end of the requested period or the announcement's release. | 23/06/2025 |
listed entity carried for record purposes only | 13/12/2006 |
As from the close of trading on Friday, 28 August 2026 the abovementioned company was removed from ASX | 28/08/2026 |
we understand the company failed to pay its annual listing fees in respect of the year ending 30 June 2027 | 28/08/2026 |
The company is currently facing the suspension of its securities from the ASX Official Quotation due to an unpaid annual listing fee for the year ending 30 June 2027. Under Listing Rule 17.15, we are required to settle this outstanding amount by 5:00 PM AEST on Friday, 28 August 2026. Immediate action is essential, as failure to complete this payment before the deadline will result in the company being permanently removed from the Official List at the close of trading on that same day. | 24/08/2026 |
Securities of the company have been suspended for over three months. Each long-term suspended entity requires its name and ASX code, details of unlodged periodic reports under Listing Rule 17.5, the one-year deadline for the oldest outstanding report, and the two-year deadline to resume trading to ASX's satisfaction. Failure to meet these deadlines results in removal from the official list, typically effective from the first trading day after the deadline. | 10/07/2026 |
Securities of companies suspended over three months will be removed from the official list if they fail to meet 1 or 2 year deadlines, effective from the next trading day after deadlines. | 17/04/2026 |
Entities suspended for over three months face deadlines for lodging outstanding reports and resuming trading. Failure to meet one or two-year deadlines results in removal from the official list, effective the next trading day. | 22/01/2026 |
Creditors resolve to place the Company Universal Biosensors Pty Limited into liquidation and the Administrators (David Hardy, James Dampney and Emily Seeckts of KPMG) are appointed Liquidators of the Company | 24/09/2025 |
The company's securities will be suspended from quotation effective immediately due to a breach of Listing Rule 12.2. This action follows the announcement of voluntary administrators being appointed to Universal Biosensors Pty Limited on August 20, 2025. ASX determined that UBI's financial condition is inadequate for continued quotation. Suspension will remain in place until UBI demonstrates compliance with Listing Rules and it is deemed appropriate for reinstatement. | 22/08/2025 |
David Hardy, James Dampney and Emily Seeckts of KPMG were appointed as joint and several voluntary administrators of Universal Biosensors Pty Limited. | 20/08/2025 |
The suspension of trading in the securities of Universal Biosensors Inc. will be lifted immediately following the release by UBI of an announcement regarding UBI signing a non-binding term sheet for a senior secured loan facility. | 02/07/2025 |
The company has signed a non-binding term sheet for a senior secured loan facility of up to A$8.5 million with Viburnum Funds Pty Ltd. The transaction is subject to securityholder approval and formal documentation negotiation. The company plans to undertake an equity raising for existing securityholders. | 02/07/2025 |
The company's securities will be suspended from quotation under Listing Rule 17.2 pending an announcement. The suspension will continue until the end of the requested period or the announcement's release. | 23/06/2025 |
listed entity carried for record purposes only | 13/12/2006 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 27/05/2024 | Graham McLean | 275,000 | $0.110 | $30,250 | |
| 27/05/2024 | Craig Coleman | 1,421,293 | $0.110 | $156,342 | |
| 11/12/2023 | Graham McLean | 75,000 | $0.199 | $14,901 | |
| 11/09/2023 | Craig Coleman | 100,000 | $0.220 | $22,000 | |
| 30/06/2023 | David Hoey | 95,983 | $0.168 | $16,120 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Graham McLean | Chairman | 07/03/2022 |
| Peter Mullin | Managing Director, CEO | 15/01/2025 |
| Judith Smith | Independent Director, Non Exec Director | 12/03/2015 |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Craig Coleman | Non Exec Director | 30/06/2016 | 30/06/2025 |
| John Sharman | Managing Director, CEO | 08/06/2020 | 01/04/2025 |
| Salesh Balak | Company Secretary | 01/11/2006 | 12/02/2025 |
| Marshall Heinberg | Non Exec Director | 11/01/2010 | 17/03/2021 |
| Rick Legleiter | CEO | 01/10/2017 | 15/07/2019 |
| David Hoey | Independent Director | 02/03/2016 | 09/08/2017 |
| Andrew Denver | Executive Chairman, CEO | 31/12/2002 | 07/08/2017 |
| Denis Hanley | Director | 21/09/2001 | 07/08/2017 |
| Paul Wright | Managing Director, CEO | 01/03/2011 | 10/03/2016 |
| Chris Smith | Non Exec Director | 27/08/2013 | 30/08/2015 |
| Andy Jane | Director | 15/08/2006 | 12/03/2015 |
| Jane Wilson | Director | 13/12/2006 | 27/08/2013 |
| Colin Adam | Director | 10/07/2002 | 16/05/2013 |
| Mark Morrisson | CEO | 15/08/2006 | 09/09/2010 |
| Charles Kiefel | Non Exec Director | 06/12/2006 | 11/01/2010 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2026 Investogain Pty Limited. All rights reserved.
